Skip to main content

2021 Oncology Drug Coding and Updates

We are pleased to present this 2021 Oncology Drug Coding and Updates special feature, designed to provide you with helpful information on the topic of oncology drug coding and important details on some of the drugs now available to treat patients with cancer. The COVID-19 pandemic led to many changes in patient care and treatment choices for oncology practices. Flexibility and innovation regarding both oral and infused/injected drugs became key to ensuring patient access to necessary treatments. Read More ›

The following tables of frequently used oncology drugs are intended to assist practice managers, other healthcare providers, and payers in the proper use of coding and billing information associated with the treatment of their patients. Read More ›

Ovarian cancer—including epithelial cancer, fallopian tube cancer, and primary peritoneal cancer—often affects women aged 55 to 64 years, with nearly 70% of all cases occurring in women aged ≥45 years. In 2020, an estimated 21,750 women will be newly diagnosed with ovarian cancer, and approximately 13,940 women will die from this disease in the United States. Read More ›

Lung and bronchus cancer is the second most prevalent form of cancer in the United States.1 Representing 12.7% of all new cancer cases, lung cancer was diagnosed in 228,820 individuals in 2020. It is the leading cause of cancer-related mortality in men and women, accounting for 22.4% of all cancer deaths. Read More ›

Epithelioid sarcoma is a rare subtype of soft-tissue sarcoma that most often occurs in the soft tissue of the fingers, hands, and forearms, but that can occur in other areas of the body. In 2005 in the United States, the incidence of epithelioid sarcoma was approximately 0.04 cases per 100,000 people. Epithelioid sarcoma predominantly affects young adults; however, it can affect individuals at any age and is more prevalent in males than in females. Characterized by slow tumor growth and benign manifestations at early stages, epithelioid sarcoma can be challenging to diagnose. Read More ›